EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE . Global Journal of Public Health Medicine, [S. l.], v. 8, n. 1 (Ongoing), p. 216–227, 2026. DOI: 10.37557/33f44713. Disponível em: https://gjphm.org/index.php/gjphm/article/view/410. Acesso em: 23 sep. 2026.